abstract |
The present invention relates to a novel tricyclic triazole compound represented by formula (I), a preparation method thereof, a composition containing it, and its use as a drug for the treatment of, for example, pain-related diseases, wherein the compound has a sigma receptor ( Especially the sigma-1 receptor) has great affinity. |